Retrieve available abstracts of 67 articles: HTML format
Single Articles
October 2025
LEOSDOTTIR M, Dahlbom L, Back M, Wallentin L, et al Data quality assessment in the SWEDEHEART registry: Insights from serial audits
on completeness and accuracy.
Am Heart J. 2025;288:149-158. PubMedAbstract available
September 2025
FEISTRITZER HJ, Jobs A, Zeymer U, Schneider S, et al Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI
and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI
trial.
Am Heart J. 2025;287:94-106. PubMedAbstract available
June 2025
CUTLIP DE, Mehran R, Doros G, Kaplinskiy V, et al Prospective randomized single-blind multicenter study to assess the safety and
effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of
subjects with in-stent restenosis: Rationale and design.
Am Heart J. 2025;284:11-19. PubMedAbstract available
May 2025
KANDZARI DE, Latib A, Mylotte D, Ali ZA, et al Rationale and design of the prevail global trial program evaluating the prevail
drug-coated balloon in patients with in-stent restenosis and de novo small vessel
disease.
Am Heart J. 2025;283:26-36. PubMedAbstract available
April 2025
HAKEEM A, Ali Shah J, Kumar R, Khan K, et al Rationale and Design of the TADCLOT Trial: A Double Blind Randomized Controlled
Trial Comparing Twice a Day Clopidogrel vs. Ticagrelor in Reducing Major Cardiac
Events in Patients with Acute STEMI Undergoing Primary Percutaneous Coronary
Intervention.
Am Heart J. 2025 Apr 12:S0002-8703(25)00103-6. doi: 10.1016/j.ahj.2025. PubMedAbstract available
SOMSEN YBO, de Winter RW, Wu J, Hoek R, et al Design and rationale of the drug-coated balloon coronary angioplasty versus
stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO)
trial.
Am Heart J. 2025 Apr 7:S0002-8703(25)00105-X. doi: 10.1016/j.ahj.2025. PubMedAbstract available
COSSETTE F, Trifan A, Prevost-Marcotte G, Doolub G, et al Tailored hydration for the prevention of contrast-induced acute kidney injury
after coronary angiogram or PCI: A systematic review and meta-analysis.
Am Heart J. 2025;282:93-102. PubMedAbstract available
March 2025
ROSOVSKY RP, Konstantinides SV, Moriarty JM, Dohad SY, et al A prospective, multicenter, randomized controlled trial evaluating
anticoagulation alone vs anticoagulation plus computer assisted vacuum
thrombectomy for the treatment of intermediate-high-risk acute pulmonary
embolism: Rationale and design of the ST
Am Heart J. 2025 Mar 31:S0002-8703(25)00100-0. doi: 10.1016/j.ahj.2025. PubMedAbstract available
HOFMANN R, James S, Sundqvist MO, Warme J, et al HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients
with acute Myocardial Infarction(HELP-MI SWEDEHEART)Design and rationale of a
cluster randomized, crossover, registry-based clinical trial.
Am Heart J. 2025 Mar 27:S0002-8703(25)00096-1. doi: 10.1016/j.ahj.2025. PubMedAbstract available
ZEYMER U, Hassinger F, Bramlage P, Schafer A, et al Hyperoxemic Oxygen Therapy in Patients with Acute Anterior Myocardial Infarction:
HOT-AAMI - Design and Rationale of a Randomized Trial.
Am Heart J. 2025 Mar 21:S0002-8703(25)00095-X. doi: 10.1016/j.ahj.2025. PubMedAbstract available
SISTA AK, Troxel AB, Tarpey T, Parpia S, et al Rationale and design of the PE-TRACT trial: A multicenter randomized trial to
evaluate catheter-directed therapy for the treatment of intermediate-risk
pulmonary embolism.
Am Heart J. 2025;281:112-122. PubMedAbstract available
February 2025
JACOBSEN MR, Jabbari R, Grove EL, Maeng M, et al Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in
patients with myocardial infarction and high bleeding risk: Design and rationale
of the investigator-initiated, multicenter, randomized, controlled trial,
DAN-DAPT.
Am Heart J. 2025 Feb 25:S0002-8703(25)00059-6. doi: 10.1016/j.ahj.2025. PubMedAbstract available
CHATUR S, Seth M, Casey M, Thompson M, et al Reminders EMbedded IN PCI Reports to Optimize Discharge Diabetes Mellitus Care
(REMIND-DM): Rationale, Design, and Baseline Characteristics.
Am Heart J. 2025 Feb 21:S0002-8703(25)00019-5. doi: 10.1016/j.ahj.2025. PubMedAbstract available
ERRIQUEZ A, Colaiori I, Hakeem A, Guiducci V, et al Functional Coronary Angiography to Indicate and Guide Revascularization in STEMI
Patients with Multivessel Disease: Rationale and Design of the AIR-STEMI trial:
Functional coronary angiography in STEMI patients.
Am Heart J. 2025 Feb 19:S0002-8703(25)00042-0. doi: 10.1016/j.ahj.2025. PubMedAbstract available
BAINEY KR, Welsh RC, Zheng Y, Arias-Mendoza A, et al Pharmaco-invasive Strategy and Dosing of Tenecteplase in STEMI Patients 60 to <75
Years: An Inter-trial Comparison of the STREAM-1 and STREAM-2 Trials: Comparison
of Patients 60 to <75 Years in STREAM-1 and -2.
Am Heart J. 2025 Feb 12:S0002-8703(25)00032-8. doi: 10.1016/j.ahj.2025. PubMedAbstract available
GAO XF, Kan J, Wu HY, Chen J, et al Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary
Intervention in Patients with Diabetes Mellitus: Rationale and design of an
International, Multicenter, Randomized IVI-DIABETES Trial.
Am Heart J. 2025 Feb 4:S0002-8703(25)00017-1. doi: 10.1016/j.ahj.2025. PubMedAbstract available
WANG G, Zhang R, Chen SL, Wang J, et al Targeted Therapy with a Localized abluminal Groove Low-Dose Sirolimus-Eluting
Bioabsorbable Polymer Coronary Stent in Chronic Total Occlusions: The TARGET CTO
Non-Inferiority Randomized Trial.
Am Heart J. 2025 Feb 3:S0002-8703(25)00018-3. doi: 10.1016/j.ahj.2025. PubMedAbstract available
January 2025
STEG PG, Nicolas J, Baber U, Sartori S, et al Characterizing High-Risk Enrollment Criteria and Impact on Clinical Outcomes in a
Large Randomized Clinical Trial: Insights From the TWILIGHT Trial.
Am Heart J. 2025 Jan 29:S0002-8703(25)00016-X. doi: 10.1016/j.ahj.2025. PubMedAbstract available
EFTEKHARI A, Christiansen EH, Lassen JF, Raungaard B, et al Randomized comparison of the combined Sirolimus eluting and endothelial
progenitor cell Combo(TM) stent vs. Biolimus eluting absorbable polymer coated
BioMatrix Alpha(TM) stent in patients undergoing percutaneous coronary
intervention. Rationale and s
Am Heart J. 2025 Jan 25:S0002-8703(25)00013-4. doi: 10.1016/j.ahj.2025. PubMedAbstract available
VELDTMAN GR, Abualsaud A, Cohen S, Ordonez MV, et al Fontan circulation and systemic disease - a retrospective cohort analysis over 35
years of follow-up.
Am Heart J. 2025;279:40-49. PubMedAbstract available
YAN S, Jiang F, Sun Y, Wang Y, et al Methylprednisolone for acute type A aortic dissection patients undergoing total
arch replacement: Design and rationale of the Medal trial.
Am Heart J. 2025;279:20-26. PubMedAbstract available
December 2024
CARULLI E, McGarvey M, Chabok M, Panoulas V, et al Transcoronary cooling and dilution for cardioprotection during revascularisation
for ST-segment elevation myocardial infarction: design and rationale of the
STEMI-Cool study.
Am Heart J. 2024 Dec 30:S0002-8703(24)00338-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
XU L, Xu H, Wu S, Zhang H, et al Indobufen-based Dual Antiplatelet Therapy in Patients with Multivessel Coronary
Disease Undergoing Drug-eluting Stent Implantation Insight From the OPTION Trial.
Am Heart J. 2024 Dec 20:S0002-8703(24)00335-1. doi: 10.1016/j.ahj.2024. PubMedAbstract available
CASSESE S, Simonetti F, Covarrubias HAA, Janisch M, et al Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary
Lithotripsy: Design and Rationale of ISAR-WAVE Trial.
Am Heart J. 2024 Dec 20:S0002-8703(24)00337-5. doi: 10.1016/j.ahj.2024. PubMedAbstract available
POLLACK LM, Chang A, Thompson MP, Keteyian SJ, et al Hospital-level variation in cardiac rehabilitation metrics.
Am Heart J. 2024 Dec 13:S0002-8703(24)00333-8. doi: 10.1016/j.ahj.2024. PubMedAbstract available
AARTS HM, Hemelrijk KI, Broeze GM, van Ginkel DJ, et al Deferral of routine percutaneous coronary intervention in patients undergoing
transcatheter aortic valve implantation: rationale and design of the PRO-TAVI
trial: the PRO-TAVI trial: rationale and design.
Am Heart J. 2024 Dec 12:S0002-8703(24)00332-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
November 2024
FANAROFF AC, Vora AN, Wojdyla DM, Mehran R, et al Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days
alive and out of hospital: An analysis from AUGUSTUS.
Am Heart J. 2024 Nov 16:S0002-8703(24)00297-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ABRAMOWITZ SD, Marko X, D'Souza D, Noor S, et al Rationale and Design of the DEFIANCE Study: A Randomized Controlled Trial of
Mechanical Thrombectomy Versus Anticoagulation Alone for Iliofemoral Deep Vein
Thrombosis.
Am Heart J. 2024 Nov 2:S0002-8703(24)00278-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ERLINGE D, Andersson J, Frobert O, Tornerud M, et al Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical
trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to
the zotarolimus-eluting Resolute Onyx stent.
Am Heart J. 2024;277:1-10. PubMedAbstract available
October 2024
BARONE-ROCHETTE G, Vanzetto G, Danchin N, Steg PG, et al Rationale and design of the multicentric randomized EVAOLD trial: evaluation of a
strategy guided by imaging versus routine invasive strategy in elderly patients
with ischemia.
Am Heart J. 2024 Oct 22:S0002-8703(24)00274-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
SAITO T, Kuno T, Fujisaki T, Gupta R, et al Dual antiplatelet therapy duration and stent type in patients with high bleeding
risk: A systematic review and network meta-analysis.
Am Heart J. 2024 Oct 5:S0002-8703(24)00266-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
September 2024
DE COCK E, Kautbally S, Timmermans F, Bogaerts K, et al Low-dose colchicine for the prevention of cardiovascular events after
percutaneous coronary intervention: rationale and design of the COL BE PCI trial:
Short title: Rationale and design of the COL BE PCI trial.
Am Heart J. 2024 Sep 2:S0002-8703(24)00225-4. doi: 10.1016/j.ahj.2024. PubMedAbstract available
August 2024
VOGEL B, Jou S, Sartori S, Farhan S, et al Impact of sex on outcomes associated with polyvascular disease in patients after
PCI.
Am Heart J. 2024 Aug 7:S0002-8703(24)00196-0. doi: 10.1016/j.ahj.2024. PubMedAbstract available
AIHARA K, Torii S, Nakamura N, Hozumi H, et al Pathological Evaluation of Predictors for Delayed Endothelial Coverage After
Currently Available Drug-eluting Stent Implantation in Coronary Arteries: Impact
of Lesions With Acute and Chronic Coronary Syndromes.
Am Heart J. 2024 Aug 7:S0002-8703(24)00197-2. doi: 10.1016/j.ahj.2024. PubMedAbstract available
STAHLI BE, Linke A, Westermann D, Van Mieghem NM, et al A Randomized Comparison of the Treatment Sequence of Percutaneous Coronary
Intervention and Transcatheter Aortic Valve Implantation: Rationale and Design of
the TAVI PCI Trial.
Am Heart J. 2024 Aug 7:S0002-8703(24)00184-4. doi: 10.1016/j.ahj.2024. PubMedAbstract available
July 2024
ERBAY A, Penzel L, Abdelwahed YS, Heuberger A, et al Prognostic impact of quantitative flow ratio (QFR)-consistent complete
revascularization in patients with myocardial infarction and multivessel coronary
artery disease.
Am Heart J. 2024 Jul 19:S0002-8703(24)00177-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
YANG Y, Chu TC, Suthar D, Beshish AG, et al Association of patient-level characteristics with long-term outcomes after Fontan
palliation: Rationale, design, and baseline characteristics of the Pediatric
Cardiac Care Consortium Fontan cohort study.
Am Heart J. 2024;273:111-120. PubMedAbstract available
June 2024
JEYAPRAKASH P, Pathan F, Ozawa K, Robledo KP, et al Restoring microvascular circulation with diagnostic ultrasound and contrast
agent: Rationale and Design of the REDUCE trial.
Am Heart J. 2024 Jun 27:S0002-8703(24)00162-5. doi: 10.1016/j.ahj.2024. PubMedAbstract available
WU ZM, Kan J, Ye F, You W, et al PCSK9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular
Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary
Intervention: A Randomized, Double- Blind, Placebo-Controlled, Multicenter SHAWN
Study.
Am Heart J. 2024 Jun 26:S0002-8703(24)00157-1. doi: 10.1016/j.ahj.2024. PubMedAbstract available
D'ENTREMONT MA, Lee SF, Mian R, Kedev S, et al Design and Rationale of the CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial
Randomized Controlled Trial of Colchicine versus placebo and Spironolactone
versus placebo in Patients with Myocardial Infarction.
Am Heart J. 2024 Jun 25:S0002-8703(24)00161-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
SONG L, Guan C, Yu M, Sun Z, et al Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium
everolimus-eluting stents in patients with coronary artery disease: rationale and
design of the IRONMAN-II trial.
Am Heart J. 2024 Jun 3:S0002-8703(24)00140-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ZHANG RS, Maqsood MH, Greco AA, Postelnicu R, et al Efficacy and safety of catheter-based thrombectomy versus catheter-directed
thrombolysis in acute pulmonary embolism.
Am Heart J. 2024;272:109-112. PubMedAbstract available
May 2024
KIM Y, Park H, Yoon HJ, Suh J, et al Fully Automated Quantitative Coronary Angiography Versus Optical Coherence
Tomography Guidance for Coronary Stent Implantation (FLASH): Study Protocol for a
Randomized Controlled Non-Inferiority Trial.
Am Heart J. 2024 May 7:S0002-8703(24)00119-4. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ZHANG F, Tian M, Wang X, Zhang H, et al Rationale and design of a Single-center Randomized Trial to Compare the Graft
Patency between the Radial Artery and the No-touch Saphenous Vein in Coronary
Artery Bypass Grafting Surgery (GRAFT-CAB Study).
Am Heart J. 2024 May 4:S0002-8703(24)00117-0. doi: 10.1016/j.ahj.2024. PubMedAbstract available
LEMLEY BA, Okunowo O, Ampah SB, Wu L, et al Effect of patient factors, center, and era on Fontan timing: An observational
study using the Pediatric Health Information Systems Database.
Am Heart J. 2024;271:156-163. PubMedAbstract available
April 2024
KIM MC, Ahn JH, Hyun DY, Lim Y, et al Timing of fractional flow reserve-guided complete revascularization in patients
with ST-segment elevation myocardial infarction with multivessel disease:
Rationale and design of the OPTION-STEMI trial.
Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024. PubMedAbstract available
WEGERIF ECJ, Unlu C, Generaal MI, van den Bor R, et al Rationale and design for the randomized placebo-controlled double-blind trial
studying the effect of single antiplatelet therapy (clopidogrel) versus dual
antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of
atherothrombotic ev
Am Heart J. 2024 Apr 10:S0002-8703(24)00080-2. doi: 10.1016/j.ahj.2024. PubMedAbstract available
March 2024
KRUCOFF M, Spirito A, Baber U, Sartori S, et al Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention
in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup
analysis of the TWILIGHT randomized clinical trial.
Am Heart J. 2024 Mar 6:S0002-8703(24)00053-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
February 2024
MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI
Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging
Studies.
Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024. PubMedAbstract available
LEE SH, Lee SJ, Heo JH, Ahn SG, et al Optimal antithrombotic strategy in patients with atrial fibrillation beyond 1
year after drug-eluting stent implantation: Design and rationale of the
randomized ADAPT AF-DES trial.
Am Heart J. 2024 Feb 22:S0002-8703(24)00041-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
DEHGHANI P, Singh J, Mancini GBJ, Stanberry L, et al Angiographic characteristics of Patients with STEMI and COVID-19 - Insights from
NACMI Registry.
Am Heart J. 2024 Feb 21:S0002-8703(24)00039-5. doi: 10.1016/j.ahj.2024. PubMedAbstract available
KEDHI E, Rroku A, Hermanides RS, Dambrink JH, et al TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided
Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve
Replacement and Coronary Bypass Grafting for Treatment of Patients with Aortic
Valve Stenosis and M
Am Heart J. 2024 Feb 1:S0002-8703(24)00019-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
January 2024
ASHWAT E, Brown JA, Yousef S, Ahmad D, et al Radial Artery versus Right Internal Mammary Artery as a Second Conduit during
Coronary Artery Bypass Grafting.
Am Heart J. 2024 Jan 20:S0002-8703(24)00015-2. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ALVIAR CL, Li BK, Keller NM, Bohula-May E, et al Prognostic Performance of the IABP-SHOCK II Risk Score Among Cardiogenic Shock
Subtypes in the Critical Care Cardiology Trials Network Registry.
Am Heart J. 2024 Jan 6:S0002-8703(23)00361-7. doi: 10.1016/j.ahj.2023. PubMedAbstract available
ZHANG RS, Ho AM, Elbaum L, Greco AA, et al Quality and rapidity of anticoagulation in patients with acute pulmonary embolism
undergoing mechanical thrombectomy.
Am Heart J. 2024;267:91-94. PubMedAbstract available
December 2023
ABU-MUCH A, Grines CL, Batchelor WB, Maini AS, et al Influence of Left Ventricular Ejection Fraction in Patients Undergoing
Contemporary pLVAD-Supported High-Risk PCI.
Am Heart J. 2023 Dec 25:S0002-8703(23)00358-7. doi: 10.1016/j.ahj.2023. PubMedAbstract available
SIREN M, Leivo J, Anttonen E, Jolly SS, et al The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment
Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of
the Randomized TOTAL Trial.
Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023. PubMedAbstract available
KANTHASAMY V, Schilling R, Zongo O, Khan K, et al Feasibility of Double-Blinded, Placebo-Controlled Interventional Study for
Assessing Catheter Ablation Efficacy in Persistent Atrial Fibrillation: Insights
from the ORBITA AF Feasibility study.
Am Heart J. 2023 Dec 16:S0002-8703(23)00353-8. doi: 10.1016/j.ahj.2023. PubMedAbstract available
DILLEN DMM, Vlaar PJ, Vermeer AJE, Paradies V, et al Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a
stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB
study.
Am Heart J. 2023;266:168-175. PubMedAbstract available
November 2023
MUNHOZ D, Collet C, Mizukami T, Yong A, et al Rationale and design of the pullback pressure gradient (PPG) global registry.
Am Heart J. 2023;265:170-179. PubMedAbstract available
October 2023
BAINEY KR, Wood DA, Bossard M, Campo G, et al Effects of Complete Revascularization According to Age in Patients with
ST-Segment Elevation Myocardial Infarction and Multivessel Disease
(COMPLETE-AGE).
Am Heart J. 2023 Oct 21:S0002-8703(23)00297-1. doi: 10.1016/j.ahj.2023. PubMedAbstract available
September 2023
PUYMIRAT E, Soulat G, Fayol A, Mousseaux E, et al Rationale and Design of the Direct Oral Anticoagulants for Prevention of Left
Ventricular Thrombus after Anterior Acute Myocardial Infarction (APERITIF) trial.
Am Heart J. 2023 Sep 14:S0002-8703(23)00278-8. doi: 10.1016/j.ahj.2023. PubMedAbstract available
GONSALVES CF, Gibson CM, Stortecky S, Alvarez RA, et al Randomized Controlled Trial of Mechanical Thrombectomy Versus Catheter-directed
Thrombolysis for Acute Hemodynamically Stable Pulmonary Embolism: Rationale and
Design of the PEERLESS Study.
Am Heart J. 2023 Sep 11:S0002-8703(23)00274-0. doi: 10.1016/j.ahj.2023. PubMedAbstract available
August 2023
PICCOLO R, Calabro P, Varricchio A, Baldi C, et al Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison
of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized
vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI.
Am Heart J. 2023 Aug 10:S0002-8703(23)00188-6. doi: 10.1016/j.ahj.2023. PubMedAbstract available
July 2023
VAN DER SANGEN NMR, Kucuk IT, Sivanesan S, Appelman Y, et al Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary
Syndrome Patients: Rationale and Design of the LEGACY study.
Am Heart J. 2023 Jul 28:S0002-8703(23)00183-7. doi: 10.1016/j.ahj.2023. PubMedAbstract available
June 2023
BUJAK K, Vidal-Cales P, Gabani R, Rinaldi R, et al Relationship between stent length and very long-term target lesion failure
following percutaneous coronary intervention for ST-elevation myocardial
infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND
study.
Am Heart J. 2023 Jun 4:S0002-8703(23)00141-2. doi: 10.1016/j.ahj.2023. PubMedAbstract available
AHN JM, Kang DY, Lee PH, Ahn YK, et al Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary
Plaque: Rationale and Design of the Randomized, Controlled PREVENT Trial.
Am Heart J. 2023 Jun 2:S0002-8703(23)00134-5. doi: 10.1016/j.ahj.2023. PubMedAbstract available